Concord Drugs Ltd Share Price
(538965)
₹30.65
as on 04:01PM, 17 Apr 2025
Concord Drugs Ltd Performance
Day's Low
Day's High
₹30.6Day's Price Range₹31.9952 Week's Low
52 Week's High
₹26.152-Week Price Range₹44.96
| Returns % | |
| 1 Month Return | -8.24 % |
| 3 Month Return | -14.76 % |
| 1 Year Return | -15.83 % |
| Market Stats | |
| Previous Close | ₹31.33 |
| Open | ₹31.60 |
| Volume | 2,687.00 |
| Upper Circuit | ₹37.59 |
| Lower Circuit | ₹25.07 |
| Market Cap | ₹30.73Cr |
Concord Drugs Ltd Fundamentals
P/E Ratio
-768.25
PEG Ratio
698.41
Market Cap
₹30.73 Cr
P/B Ratio
1.04
EPS
0.47
Dividend Yield
0Sector
Pharmaceuticals
ROE
1.28
Key events for Concord Drugs Ltd
Concord Drugs Reports Mixed Financial Performance - 15 Jan, 2025
Concord Drugs reported a 14.66% decline in net sales to Rs 10.77 crore for December 2024, while net profit rose 192.68% to Rs 0.22 crore. EBITDA increased by 135.71%. The stock has seen a -3.28% return over the last 6 months and -14.53% over the last year.
Insights on Concord Drugs Ltd
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
POSITIVE IMPACTProfit Spike
Netprofit is up for the last 4 quarters, -0.34 Cr → 0.23 Cr (in ₹), with an average increase of 447.0% per quarter
NO EFFECTAgainst Peers
In the last 1 year, Divis Laboratories Ltd has given 52.1% return, outperforming this stock by 68.0%
- NO EFFECT
Retail Holding Unchanged
Retail Investor holdings remained unchanged at 45.61% of holdings in Dec 2024 quarter
- NO EFFECT
Against Peers
In the last 3 years, Torrent Pharmaceuticals Ltd has given 128.1% return, outperforming this stock by 128.0%
- NO EFFECT
Promoter Holding Unchanged
Promoters holdings remained unchanged at 54.39% of holdings in Dec 2024 quarter
NEGATIVE IMPACTPrice Dip
In the last 7 days, Concord Drugs stock has moved down by -1.8%
- NEGATIVE IMPACT
Revenue Fall
Revenue is down for the last 2 quarters, 12.37 Cr → 10.8 Cr (in ₹), with an average decrease of 12.7% per quarter
Concord Drugs Ltd Financials
Concord Drugs Ltd Shareholding Pattern
| Investors | Holdings % | FY Quarter | 3M change |
|---|---|---|---|
| Promoter Holdings | 54.39% | 0.00 | |
| Foreign Institutions | 0% | 0.00 | |
| Mutual Funds | 0% | 0.00 | |
| Retail Investors | 45.61% | 0.00 | |
| Others | 0% | 0.00 |
Concord Drugs Ltd Key Indicators
Concord Drugs Ltd Valuation
Concord Drugs Ltd in the last 5 years
Lowest (-961.50x)
January 3, 2025
Today (-768.25x)
April 17, 2025
Industry (53.02x)
April 17, 2025
Highest (791.40x)
July 3, 2024
Concord Drugs Ltd Earnings and Dividends
Concord Drugs Ltd Earnings Results
Concord Drugs Ltd’s net profit jumped 195.83% since last year same period to ₹0.23Cr in the Q3 2024-2025. On a quarterly growth basis, Concord Drugs Ltd has generated 475% jump in its net profits since last 3-months.
Read More about Earnings Results
Concord Drugs Ltd Technicals Summary
Bearish
Neutral
Bullish
Concord Drugs Ltd is currently in a Bearish trading position according to technical analysis indicators.
Concord Drugs Ltd Peer Comparison
Company | Analyst View | Market Cap | 5 Year CAGR | Debt to Asset Ratio | Net Profit | Yearly Revenue |
|---|---|---|---|---|---|---|
| NA | ₹30.73 Cr | 15.51% | 0.67 | ₹1 Cr | ₹44 Cr | |
| NA | ₹472.34 Cr | 27.04% | 0.57 | NA | NA | |
| NA | ₹71.27 Cr | -0.51% | 0.57 | NA | NA | |
| NA | ₹246.55 Cr | 107.53% | 0.66 | ₹5 Cr | ₹155 Cr | |
| NA | ₹177.04 Cr | 53.55% | 0.62 | NA | NA |
About Concord Drugs Ltd
Revenue: ₹10.80Cr as on December 2024 (Q4 24)
Net Profit: ₹0.23Cr as on December 2024 (Q4 24)
Chairperson Name: S Nagi Reddy
| Organisation | Concord Drugs Ltd |
| Headquarters | |
| Industry | Pharmaceuticals |
| E-voting on shares | Click here to vote |
FAQs on Concord Drugs Ltd
What is Concord Drugs Ltd price today?
Concord Drugs Ltd share price today stands at ₹30.65, Open: ₹31.6, Previous Close: ₹31.33, High: ₹31.99, Low: ₹30.6, 52 Week High: ₹44.96, 52 Week Low: ₹26.1.
How to Buy Concord Drugs Ltd Share in India?
- Get a PAN card
- Open a Demat account
- Open a Trading account
- Link your Demat account to your Trading account
- Fund your Trading account
- Place an order to buy Concord Drugs Ltd shares
What are today's traded volumes of Concord Drugs Ltd?
Today's traded volume of Concord Drugs Ltd(538965) is 2,687.00.
What is today's market capitalisation of Concord Drugs Ltd?
Today's market capitalisation of Concord Drugs Ltd(538965) is ₹30.73Cr.
What is the 52 Week High and Low Range of Concord Drugs Ltd?
How much percentage Concord Drugs Ltd is down from its 52 Week High?
Concord Drugs Ltd (538965) share price is ₹30.65. It is down -31.83% from its 52 Week High price of ₹44.96
How much percentage Concord Drugs Ltd is up from its 52 Week low?
Concord Drugs Ltd (538965) share price is ₹30.65. It is up 17.43% from its 52 Week Low price of ₹26.1